Iborra I - Search Results

1

Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens.

Rubio J, Ramos D, López-Guerrero JA, Iborra I, Collado A, Solsona E, Almenar S, Llombart-Bosch A. Rubio J, et al. Among authors: iborra i. Eur Urol. 2005 Nov;48(5):745-51. doi: 10.1016/j.eururo.2005.06.014. Epub 2005 Jul 11. Eur Urol. 2005. PMID: 16139948

2

The prostate involvement as prognostic factor in patients with superficial bladder tumors.

Solsona E, Iborra I, Ricós JV, Monrós JL, Casanova JL, Almenar S. Solsona E, et al. Among authors: iborra i. J Urol. 1995 Nov;154(5):1710-3. J Urol. 1995. PMID: 7563328

3

The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer.

Solsona E, Iborra I, Dumont R, Rubio-Briones J, Casanova J, Almenar S. Solsona E, et al. Among authors: iborra i. J Urol. 2000 Sep;164(3 Pt 1):685-9. doi: 10.1097/00005392-200009010-00016. J Urol. 2000. PMID: 10953125

4

Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.

Solsona E, Iborra I, Ricos JV, Monros JL, Rubio J, Almenar S. Solsona E, et al. Among authors: iborra i. J Urol. 2002 May;167(5):2007-11. J Urol. 2002. PMID: 11956428

5

Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression.

Iborra I, Solsona E, Casanova J, Ricós JV, Rubio J, Climent MA. Iborra I, et al. J Urol. 2003 Jan;169(1):82-5. doi: 10.1016/S0022-5347(05)64041-4. J Urol. 2003. PMID: 12478109

6

Late oncological occurrences following radical cystectomy in patients with bladder cancer.

Solsona E, Iborra I, Rubio J, Casanova J, Dumont R, Monrós JL. Solsona E, et al. Among authors: iborra i. Eur Urol. 2003 May;43(5):489-94. doi: 10.1016/s0302-2838(03)00100-3. Eur Urol. 2003. PMID: 12705992

7

Risk groups in patients with bladder cancer treated with radical cystectomy: statistical and clinical model improving homogeneity.

Solsona E, Iborra I, Dumont R, Rubio J, Casanova JL, Almenar S. Solsona E, et al. Among authors: iborra i. J Urol. 2005 Oct;174(4 Pt 1):1226-30. doi: 10.1097/01.ju.0000173920.31824.2f. J Urol. 2005. PMID: 16145375

8

[Metastatic progression, cancer-specific mortality and need for secondary treatments in patients with clinically high-risk prostate cancer treated initially with radical prostatectomy].

Rubio-Briones J, Iborra I, Trassierra M, Collado A, Casanova J, Gómez-Ferrer A, Ricós JV, Monrós JL, Dumont R, Solsona E. Rubio-Briones J, et al. Among authors: iborra i. Actas Urol Esp. 2010 Jul;34(7):610-7. Actas Urol Esp. 2010. PMID: 20540878 Spanish.

9

Long-term oncological results of treatment for high-risk prostate cancer using radical prostatectomy in a cancer hospital.

Rubio-Briones J, Ramírez-Backhaus M, Gómez-Ferrer A, Mir C, Domínguez-Escrig J, Collado A, Iborra I, Casanova J, Solsona E, Mascarós JM, Calatrava A. Rubio-Briones J, et al. Among authors: iborra i. Actas Urol Esp (Engl Ed). 2018 Oct;42(8):507-515. doi: 10.1016/j.acuro.2018.02.007. Epub 2018 Apr 7. Actas Urol Esp (Engl Ed). 2018. PMID: 29631913 English, Spanish.

10

Corpus cavernosum invasion and tumor grade in the prediction of lymph node condition in penile carcinoma.

Solsona E, Iborra I, Ricós JV, Monrós JL, Dumont R, Casanova J, Calabuig C. Solsona E, et al. Among authors: iborra i. Eur Urol. 1992;22(2):115-8. doi: 10.1159/000474736. Eur Urol. 1992. PMID: 1478225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters